Fraher L J, Adami S, Papapoulos S E, Sudan H L, McGonigle R J, Parsons V, O'Riordan J L
Clin Sci (Lond). 1986 Jul;71(1):89-95. doi: 10.1042/cs0710089.
Metabolites of vitamin D3 were measured in the circulation of four patients on chronic haemodialysis (three of whom were surgically anephric) before and during daily ingestion of 40 000 i.u. of cholecalciferol. Circulating 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] was measurable, but abnormally low before treatment; its circulating concentration rose in a substrate dependent manner when serum 25-hydroxyvitamin D3 (25-OHD3) increased, but the response was reduced when compared with the normal relationship. Serum 1,25-hydroxyvitamin D3 [1,25-(OH)2D3] and calcidiol lactone (25-OHD3-lactone) were consistently unmeasurable in sera from these patients before administration of cholecalciferol. However, when serum 25-OHD3 rose with treatment, 1,25-(OH)2D3 became detectable in the sera of three of the four patients and 25-OHD3-lactone could be measured in all of them. These data indicate that extrarenal sites of synthesis of 24,25-(OH)2D3, 25-OHD3-lactone and 1,25-(OH)2D3 exist in chronically dialysed patients but require large amounts of substrate to be significant.
对4例慢性血液透析患者(其中3例为手术切除双肾者)在每日摄入40000国际单位胆钙化醇之前和期间,检测其循环系统中维生素D3的代谢产物。循环中的24,25 - 二羟维生素D3 [24,25-(OH)2D3] 可检测到,但治疗前水平异常低;当血清25 - 羟维生素D3(25 - OHD3)升高时,其循环浓度以底物依赖的方式上升,但与正常关系相比,反应有所降低。在给予胆钙化醇之前,这些患者血清中的1,25 - 二羟维生素D3 [1,25-(OH)2D3] 和骨化二醇内酯(25 - OHD3 - 内酯)始终无法检测到。然而,治疗后当血清25 - OHD3升高时,4例患者中有3例血清中可检测到1,25-(OH)2D3,所有患者均可检测到25 - OHD3 - 内酯。这些数据表明,慢性透析患者体内存在24,25-(OH)2D3、25 - OHD3 - 内酯和1,25-(OH)2D3的肾外合成部位,但需要大量底物才能产生显著影响。